BSE Live
Jan 30, 12:13Prev. Close
288.40
Open Price
285.20
Bid Price (Qty.)
287.00 (1)
Offer Price (Qty.)
287.85 (18)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
Balance Sheet of Titan Biotech (in Rs. Cr.) | Mar 22 | Mar 21 | Mar 20 | Mar 19 | Mar 18 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
EQUITIES AND LIABILITIES | ||||||
SHAREHOLDER'S FUNDS | ||||||
Equity Share Capital | 8.26 | 8.26 | 8.26 | 8.26 | 7.74 | |
Total Share Capital | 8.26 | 8.26 | 8.26 | 8.26 | 7.74 | |
Reserves and Surplus | 77.98 | 57.56 | 29.55 | 23.40 | 16.54 | |
Total Reserves and Surplus | 77.98 | 57.56 | 29.55 | 23.40 | 16.54 | |
Total Shareholders Funds | 86.24 | 65.82 | 37.81 | 31.66 | 24.28 | |
NON-CURRENT LIABILITIES | ||||||
Long Term Borrowings | 1.08 | 1.83 | 8.48 | 12.02 | 17.47 | |
Deferred Tax Liabilities [Net] | 1.28 | 1.35 | 1.20 | 1.02 | 0.73 | |
Other Long Term Liabilities | 1.11 | 1.40 | 0.00 | 0.00 | 0.00 | |
Long Term Provisions | 1.43 | 1.41 | 1.24 | 0.96 | 1.62 | |
Total Non-Current Liabilities | 4.90 | 5.98 | 10.91 | 13.99 | 19.82 | |
CURRENT LIABILITIES | ||||||
Short Term Borrowings | 4.72 | 5.71 | 8.41 | 8.84 | 7.10 | |
Trade Payables | 4.16 | 2.68 | 3.57 | 2.06 | 1.06 | |
Other Current Liabilities | 7.26 | 5.97 | 4.49 | 3.26 | 2.68 | |
Short Term Provisions | 0.29 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Current Liabilities | 16.42 | 14.37 | 16.47 | 14.16 | 10.85 | |
Total Capital And Liabilities | 107.56 | 86.17 | 65.20 | 59.82 | 54.95 | |
ASSETS | ||||||
NON-CURRENT ASSETS | ||||||
Tangible Assets | 34.88 | 26.95 | 25.14 | 25.81 | 10.73 | |
Intangible Assets | 0.10 | 0.09 | 0.10 | 0.09 | 0.19 | |
Capital Work-In-Progress | 3.63 | 0.27 | 0.00 | 0.00 | 13.28 | |
Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Fixed Assets | 38.62 | 27.31 | 25.24 | 25.90 | 24.20 | |
Non-Current Investments | 4.03 | 1.27 | 1.27 | 1.27 | 1.27 | |
Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Other Non-Current Assets | 1.69 | 7.45 | 0.58 | 0.56 | 0.54 | |
Total Non-Current Assets | 44.34 | 36.03 | 27.09 | 27.74 | 26.01 | |
CURRENT ASSETS | ||||||
Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Inventories | 34.68 | 26.83 | 24.14 | 19.96 | 17.19 | |
Trade Receivables | 16.36 | 16.12 | 10.54 | 7.84 | 8.04 | |
Cash And Cash Equivalents | 6.81 | 5.49 | 1.73 | 1.75 | 1.19 | |
Short Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
OtherCurrentAssets | 5.37 | 1.70 | 1.70 | 2.53 | 2.52 | |
Total Current Assets | 63.23 | 50.14 | 38.11 | 32.07 | 28.93 | |
Total Assets | 107.56 | 86.17 | 65.20 | 59.82 | 54.95 | |
OTHER ADDITIONAL INFORMATION | ||||||
CONTINGENT LIABILITIES, COMMITMENTS | ||||||
Contingent Liabilities | 3.20 | 0.77 | 0.00 | 0.00 | 0.00 | |
CIF VALUE OF IMPORTS | ||||||
Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
EXPENDITURE IN FOREIGN EXCHANGE | ||||||
Expenditure In Foreign Currency | 20.90 | 20.13 | 14.53 | 21.77 | 11.91 | |
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
EARNINGS IN FOREIGN EXCHANGE | ||||||
FOB Value Of Goods | 27.63 | 23.88 | 13.65 | 13.90 | 14.63 | |
Other Earnings | 1.17 | 0.84 | 1.16 | 0.66 | 0.23 | |
BONUS DETAILS | ||||||
Bonus Equity Share Capital | -- | -- | -- | -- | -- | |
NON-CURRENT INVESTMENTS | ||||||
Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
Non-Current Investments Unquoted Book Value | 4.03 | 1.27 | 1.27 | 1.27 | 1.27 | |
CURRENT INVESTMENTS | ||||||
Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
14.11.2022
Titan Biotech Consolidated September 2022 Net Sales at Rs 41.83 crore, up 2.4% Y-o-Y
14.11.2022
Titan Biotech Standalone September 2022 Net Sales at Rs 41.83 crore, up 41.03% Y-o-Y
10.08.2022
Titan Biotech Consolidated June 2022 Net Sales at Rs 35.00 crore, down 15.55% Y-o-Y
10.08.2022
Titan Biotech Standalone June 2022 Net Sales at Rs 35.00 crore, up 6.62% Y-o-Y
14.11.2022
Titan Biotech Consolidated September 2022 Net Sales at Rs 41.83 crore, up 2.4% Y-o-Y
14.11.2022
Titan Biotech Standalone September 2022 Net Sales at Rs 41.83 crore, up 41.03% Y-o-Y
10.08.2022
Titan Biotech Consolidated June 2022 Net Sales at Rs 35.00 crore, down 15.55% Y-o-Y
10.08.2022
Titan Biotech Standalone June 2022 Net Sales at Rs 35.00 crore, up 6.62% Y-o-Y
15.02.2017
15.02.2017
14.02.2017
13.02.2017